Accordingly, we examined the expression levels of SOCS2 recorded in a publicly available gene expression dataset (NCBI GEO) for mononuclear cells collected from a panel of AML and CML patients. This evidence concerns the gene SOCS2 and chronic myelogenous leukemia, BCR-ABL1 positive.